Search: WFRF:(Ericsson Johanna 1978) > Epigallocatechin ga...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05021naa a2200685 4500 | |
001 | oai:gup.ub.gu.se/50354 | |
003 | SwePub | |
008 | 240528s2006 | |||||||||||000 ||eng| | |
024 | 7 | a https://gup.ub.gu.se/publication/503542 URI |
024 | 7 | a https://doi.org/10.1194/jlr.M500424-JLR2002 DOI |
040 | a (SwePub)gu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Li, Lu,d 1964u Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Wallenberg Laboratory4 aut0 (Swepub:gu)xlilui |
245 | 1 0 | a Epigallocatechin gallate increases the formation of cytosolic lipid droplets and decreases the secretion of apoB-100 VLDL |
264 | 1 | c 2006 |
520 | a Epigallocatechin gallate (EGCG) increases the formation of cytosolic lipid droplets by a mechanism that is independent of the rate of triglyceride biosynthesis and involves an enhanced fusion between lipid droplets, a process that is crucial for their growth in size. EGCG treatment reduced the secretion of both triglycerides and apolipoprotein B-100 (apoB-100) VLDLs but not of transferrin, albumin, or total proteins, indicating that EGCG diverts triglycerides from VLDL assembly to storage in the cytosol. This is further supported by the observed increase in both intracellular degradation of apoB-100 and ubiquitination of the protein (indicative of increased proteasomal degradation) in EGCG-treated cells. EGCG did not interfere with the microsomal triglyceride transfer protein, and the effect of EGCG on the secretion of VLDLs was found to be independent of the LDL receptor. Thus, our results indicate that EGCG promotes the accumulation of triglycerides in cytosolic lipid droplets, thereby diverting lipids from the assembly of VLDL to storage in the cytosol. Our results also indicate that the accumulation of lipids in the cytosol is not always associated with increased secretion of VLDL. | |
653 | a Adipocytes/drug effects/metabolism | |
653 | a Animals | |
653 | a Apolipoprotein B-100 | |
653 | a Apolipoproteins B/genetics/*metabolism | |
653 | a Base Sequence | |
653 | a Catechin/*analogs & derivatives/pharmacology | |
653 | a Cell Line | |
653 | a Cytosol/drug effects/metabolism | |
653 | a DNA | |
653 | a Complementary/genetics | |
653 | a Heparin/pharmacology | |
653 | a Humans | |
653 | a Lipid Metabolism/*drug effects | |
653 | a Lipids/blood | |
653 | a Lipoproteins/blood | |
653 | a Lipoproteins | |
653 | a VLDL/*metabolism | |
653 | a Membrane Proteins/genetics/metabolism | |
653 | a Mice | |
653 | a Mice | |
653 | a Transgenic | |
653 | a NIH 3T3 Cells | |
653 | a Rats | |
653 | a Receptors | |
653 | a LDL/drug effects/metabolism | |
653 | a Recombinant Proteins/genetics/metabolism | |
700 | 1 | a Stillemark-Billton, Pia,d 1968u Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Wallenberg Laboratory4 aut0 (Swepub:gu)xstipi |
700 | 1 | a Beck, Caroline,d 1976u Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Wallenberg Laboratory4 aut0 (Swepub:gu)xbecca |
700 | 1 | a Boström, Pontus,d 1982u Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Wallenberg Laboratory4 aut0 (Swepub:gu)xbospo |
700 | 1 | a Andersson, Linda,d 1973u Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Wallenberg Laboratory4 aut0 (Swepub:gu)xanlin |
700 | 1 | a Rutberg, Mikael,d 1959u Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Wallenberg Laboratory4 aut0 (Swepub:gu)xrutmi |
700 | 1 | a Ericsson, Johanna,d 1978u Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Wallenberg Laboratory4 aut |
700 | 1 | a Magnusson, Björn,d 1976u Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Wallenberg Laboratory4 aut0 (Swepub:gu)xmagnb |
700 | 1 | a Marchesan, Denis,d 1968u Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Wallenberg Laboratory4 aut |
700 | 1 | a Ljungberg, Anna,d 1977u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för fysiologi,Institute of Neuroscience and Physiology, Department of Physiology4 aut0 (Swepub:gu)xljuan |
700 | 1 | a Borén, Jan,d 1963u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Wallenberglaboratoriet,Institute of Medicine, Department of Molecular and Clinical Medicine,Wallenberg Laboratory4 aut0 (Swepub:gu)xborej |
700 | 1 | a Olofsson, Sven-Olof,d 1947u Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Wallenberg Laboratory4 aut0 (Swepub:gu)xolosv |
710 | 2 | a Göteborgs universitetb Wallenberglaboratoriet4 org |
773 | 0 | t J Lipid Resg 47:1, s. 67-77q 47:1<67-77x 0022-2275 |
856 | 4 8 | u https://gup.ub.gu.se/publication/50354 |
856 | 4 8 | u https://doi.org/10.1194/jlr.M500424-JLR200 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Copy and save the link in order to return to this view